Biotech · Private company
Prescient Therapeutics, Ltd.
Track this companyFree. Adds Prescient Therapeutics, Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- CarboplatinPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 2 · Breast AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CytarabinePhase 2 · Acute LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Doxorubicin HydrochloridePhase 2 · Breast AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Laboratory Biomarker AnalysisPhase 2 · Breast AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 2 · Breast AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PTX-100Phase 2 · CTCLClinicalTrials.gov · fetched Nov 12, 2026
- PTX-200Phase 2 · Acute LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Therapeutic Conventional SurgeryPhase 2 · Breast AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TriciribinePhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Triciribine PhosphatePhase 2 · Breast AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCLPHASE2 · RECRUITING · started Mar 28, 2025ClinicalTrials.gov NCT06854653 · fetched Nov 12, 2026
- A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute LeukemiaPHASE1_PHASE2 · COMPLETED · started Dec 9, 2016ClinicalTrials.gov NCT02930109 · fetched Nov 12, 2026
- PTX-200 and Carboplatin in Ovarian CancerPHASE1_PHASE2 · TERMINATED · started Sep 1, 2014ClinicalTrials.gov NCT01690468 · fetched Nov 12, 2026
- PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast CancerPHASE1_PHASE2 · TERMINATED · started Jan 1, 2012ClinicalTrials.gov NCT01697293 · fetched Nov 12, 2026